Please login to the form below

Not currently logged in
Email:
Password:

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Research

Roche to buy cancer data firm Flatiron for $1.9bn

Roche Basel SwitzerlandData provides a wealth of RWE opportunities

From: Research

Merck/Pfizer’s cancer immunotherapy latecomer hits a snag

Merck KGaABavencio fails a key lung cancer trial

From: Research

BMS pens massive $3.6bn deal for Nektar cancer immunotherapy

Bristol-Myers Squibb (BMS) buildingNektar’s NKTR-214 to be paired with Opdivo and Yervoy in a host of tumour types

From: Regulatory

J&J’s Erleada first US drug for non-metastatic prostate cancer

Drug approved by the FDA on the back of data from the SPARTAN study

Articles

Pharmaceutical Market Europe - February 2018

In this month’s PME there's insight from UCB, Insmed and Merck

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Dominic Tyer

Have your say...

Ablynx reshuffles its board again

Dr Bo Jesper Hansen resigns from the Belgium biotech's board

Bo Jesper Hensen

'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

Novartis telehealth service to be ramped up in Ghana

Country's health service selects it as part of the national eHealth strategy

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Finding the patient voice
How patients feel and speak about clinical trials...
Six Factors to Consider When Designing Advisory Boards
...
The good, the bad and the ugly
Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 - it’s a trilogy of trends...

Infographics